Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146967
Max Phase: Preclinical
Molecular Formula: C65H98N14O10
Molecular Weight: 1235.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2146967
Max Phase: Preclinical
Molecular Formula: C65H98N14O10
Molecular Weight: 1235.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@@H]1NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC(=O)[C@H](C23CC4CC(CC(C4)C2)C3)NC(=O)[C@H](CCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCCN)NC1=O
Standard InChI: InChI=1S/C65H98N14O10/c1-39(2)53-61(86)72-45(19-9-25-66)55(80)74-49(34-40-15-5-3-6-16-40)63(88)79-30-14-24-52(79)60(85)71-48(22-12-28-69)58(83)77-54(65-36-42-31-43(37-65)33-44(32-42)38-65)62(87)73-46(20-10-26-67)56(81)75-50(35-41-17-7-4-8-18-41)64(89)78-29-13-23-51(78)59(84)70-47(21-11-27-68)57(82)76-53/h3-8,15-18,39,42-54H,9-14,19-38,66-69H2,1-2H3,(H,70,84)(H,71,85)(H,72,86)(H,73,87)(H,74,80)(H,75,81)(H,76,82)(H,77,83)/t42?,43?,44?,45-,46-,47-,48-,49+,50+,51-,52-,53-,54+,65?/m0/s1
Standard InChI Key: RDBGEDJRWFALEZ-GJTFHWTASA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1235.59 | Molecular Weight (Monoisotopic): 1234.7590 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kapoerchan VV, Knijnenburg AD, Keizer P, Spalburg E, de Neeling AJ, Mars-Groenendijk RH, Noort D, Otero JM, Llamas-Saiz AL, van Raaij MJ, van der Marel GA, Overkleeft HS, Overhand M.. (2012) 'Inverted' analogs of the antibiotic gramicidin S with an improved biological profile., 20 (20): [PMID:22989907] [10.1016/j.bmc.2012.08.038] |
Source(1):